IL18 and neoplasm: In vitro data also show that IL-18 can favor the differentiation of human CD56dim CCR7+ CD25+ CD83+ helper NK cells, which control tumor dissemination and CD8+ T cell activation through the crosstalk with DCs in the lymph nodes (40, 41, 105).